Neogen Stock Math Operators Price Series Summation
| NEOG Stock | USD 9.68 -0.02 -0.21% |
| Symbols |
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Neogen Price Series Summation is a cross summation of Neogen price series and its benchmark/peer.
Neogen Technical Analysis Modules
Most technical analysis of Neogen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neogen from various momentum indicators to cycle indicators. When you analyze Neogen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
What Is Neogen Worth Today?
Neogen is a large-cap equity in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care categories. Profitability trends drive pricing sustainability. We review the company from a portfolio-construction standpoint emphasizing diversification and stability.
Methodology
Unless otherwise specified, financial data for Neogen is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Neogen (USA Stocks:NEOG) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Neogen is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, among others. Updates may occur throughout the day.
Become your own money manager
Tracking Neogen inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 20 shares | |
 | Synthetics Invested over 60 shares | |
 | Power Assets Invested over 200 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Momentum Invested over 20 shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Driverless Cars Invested few shares |
More Resources for Neogen Stock Analysis
A comprehensive view of Neogen starts with financial statements and ratio context. Ratios and trend metrics help frame Neogen's operating context. Highlighted below are reports that provide context for Neogen Stock:Review Correlation Analysis to understand diversified portfolio construction. Broader allocation clarity strengthens diversification analysis. This suggests a position in Neogen inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Ready to invest in Neogen Stock? Our How to Invest in Neogen guide walks you through the process.Analysis related to Neogen should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Quarterly Earnings Growth -0.86 | Earnings Share -2.78 | Revenue Per Share | Quarterly Revenue Growth -0.03 | Return On Assets |
Understanding Neogen includes distinguishing between market value and book value, where book value reflects Neogen accounting equity. Intrinsic value is an estimate of what Neogen's fundamentals imply, and it may differ from market and book figures. External forces such as sentiment and macro conditions can shift prices away from fundamental signals. Analytical frameworks help compare those viewpoints.
The concept of value for Neogen differs from its quoted price, since each reflects a different lens. Evaluation typically reviews profitability, growth, balance sheet strength, industry position, and market signals. Market price reflects the current exchange level formed by active bids and offers.